Vitamin D-VDR (vitamin D Receptor) Regulates Defective Autophagy in Renal Tubular Epithelial Cell in Streptozotocin-induced Diabetic Mice Via the AMPK Pathway
Overview
Affiliations
Diabetic nephropathy (DN) has become a major cause of end-stage renal disease, and autophagy disorder is implicated in the pathogenesis of DN. Our previous studies found that vitamin D (VD) and VDR (vitamin D receptor) played a renoprotective role by inhibiting inflammation and fibrosis. However, whether VD-VDR regulates autophagy disorders in DN remains unclear. In this study, we established a streptozotocin (STZ)-induced diabetic model in knockout (-KO) mice and VDR specifically overexpressed in renal proximal tubular epithelial cells (-OE) mice. Our results showed that paricalcitol (an activated vitamin D analog) or -OE could alleviate STZ-induced ALB (albumin) excretion, renal tubule injury and inflammation, while these were worsened in -KO mice. Defective autophagy was observed in the kidneys of STZ mice, which was more pronounced in -KO mice and could be partially restored by paricalcitol or -OE. In high glucose-induced HK-2 cells, defective autophagy and decreased PRKAA1/AMPK phosphorylation was observed, which could be partially restored by paricalcitol in a VDR-dependent manner. AMPK inhibitor abolished paricalcitol-induced autophagy activation, and AMPK activator restored the defective autophagy in high glucose-induced HK-2 cells. Furthermore, paricalcitol-mediated AMPK activation was abrogated by CAMKK2/CaMKKβ inhibition, but not by knockout. Meanwhile, paricalcitol rescued the decreased Ca concentration induced by high glucose. In conclusion, VD-VDR can restore defective autophagy in the kidney of STZ-induced diabetic mice, which could be attributed to the activation of the Ca-CAMKK2-AMPK pathway in renal tubular epithelial cells. ACTB/β-actin: actin beta;AGE: advanced glycation end-products;AMPK: AMP-activated protein kinase;CAMKK2/CaMKKβ: calcium-calmodulin dependent protein kinase kinase 2;CQ: chloroquine;DN: diabetic nephropathy;HG: high levels of glucose;KO: knockout;LG: low levels of glucose;MAP1LC3/LC3: microtubule associated protein 1 light chain 3;NOD2: nucleotide binding oligomerization domain containing 2;OE: overexpression;PAS: periodic acid Schiff; Pari: paricalcitol;PTECs: proximal renal tubule epithelial cells;RT: room temperature;SQSTM1/p62: sequestosome 1;STK11/LKB1: serine/threonine kinase 11;STZ: streptozotocin;TEM: transmission electron microscopy;VD: vitamin D;VDR: vitamin D receptor;WT: wild-type.
Fuentes-Barria H, Aguilera-Eguia R, Flores-Fernandez C, Angarita-Davila L, Rojas-Gomez D, Alarcon-Rivera M Int J Mol Sci. 2025; 26(5).
PMID: 40076782 PMC: 11900948. DOI: 10.3390/ijms26052153.
Lu M, Zhan Z, Li D, Chen H, Li A, Hu J Redox Biol. 2025; 80:103518.
PMID: 39891958 PMC: 11836507. DOI: 10.1016/j.redox.2025.103518.
Hu M, Deng Y, Bai Y, Zhang J, Shen X, Shen L J Inflamm Res. 2025; 18:949-972.
PMID: 39871959 PMC: 11769850. DOI: 10.2147/JIR.S482047.
Zhu Z, Luan G, Wu S, Song Y, Shen S, Wu K J Transl Med. 2025; 23(1):90.
PMID: 39838394 PMC: 11748887. DOI: 10.1186/s12967-025-06074-5.
Xanthohumol attenuates TXNIP-mediated renal tubular injury in vitro and in vivo diabetic models.
Zhang Y, Pan R, Shou Z, Zhao Y J Nat Med. 2025; 79(2):314-327.
PMID: 39752106 DOI: 10.1007/s11418-024-01863-6.